Search - tctmd.com

Displaying 101 - 120 of 176

Sort: Relevancy | Date

Presentation THT 2024

Current Understanding of the Incidence, Characteristics, and Sustainability of "Recoverers" in Response to LVAD Support

Presenter: Emma Birks

March 04, 2024

Presentation THT 2024

A Heart Team Approach to Management of TR in Patients With Cardiac Implantable Electronic Device Leads (CEIDs)

Presenter: Rebecca T. Hahn

March 04, 2024

Presentation THT 2024

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

Presenter: Sean P. Pinney

March 04, 2024

Presentation THT 2024

The TMVR Landscape: Second Generation Devices and Clinical Trial Pathways

Presenter: Martin B. Leon

March 04, 2024

Presentation THT 2024

Reducing Congestion by Removing Fluid From the Interstitium

Presenter: William T. Abraham

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Presenter: Jennifer A. Cowger

March 04, 2024

Presentation THT 2024

Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials

Presenter: James Januzzi

March 04, 2024

Presentation THT 2024

Mechanisms of Diuretic Resistance

Presenter: Jeffrey Testani

March 04, 2024

Presentation THT 2024

Contemporary Pharmacological Therapies for Acute Heart Failure

Presenter: Wilfried Mullens

March 04, 2024

Presentation THT 2024

Left-to-Right Shunting for Chronic Heart Failure: Overview of the Device Landscape

Presenter: Benjamin Hibbert

March 04, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

Shelley Wood

March 24, 2023

News Conference News THT 2023

Meta-analysis Hints at Survival Benefit With LAP Monitoring in HFrEF

Shelley Wood

March 22, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

News Conference News THT 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

Todd Neale

March 22, 2023

Presentation THT 2023

Overview of Transcatheter Devices for FMR

Presenter: Scott Lim

March 22, 2023

Presentation THT 2023

Treatment Algorithms: Matching Devices With Anatomy and Clinical Factors

Presenter: Azeem Latib

March 22, 2023

Presentation THT 2023

Clinical Feasibility of a Novel Right-to-Right Cardiac Shunt in Pulmonary Hypertension using Off-the-Shelf Devices

Presenter: David Lim

March 22, 2023

Advertisement

Current Understanding of the Incidence, Characteristics, and Sustainability of "Recoverers" in Response to LVAD Support

A Heart Team Approach to Management of TR in Patients With Cardiac Implantable Electronic Device Leads (CEIDs)

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

The TMVR Landscape: Second Generation Devices and Clinical Trial Pathways

Reducing Congestion by Removing Fluid From the Interstitium

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials

Mechanisms of Diuretic Resistance

Contemporary Pharmacological Therapies for Acute Heart Failure

Left-to-Right Shunting for Chronic Heart Failure: Overview of the Device Landscape

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

Meta-analysis Hints at Survival Benefit With LAP Monitoring in HFrEF

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

Overview of Transcatheter Devices for FMR

Treatment Algorithms: Matching Devices With Anatomy and Clinical Factors

Clinical Feasibility of a Novel Right-to-Right Cardiac Shunt in Pulmonary Hypertension using Off-the-Shelf Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content